In conclusion, our present study demonstrated for the first time that the GPR4/STAT3/VEGFA signaling pathway contributed to the impaired angiogenic capacity of EPCs and that elevating GPR4 could restore the angiogenic capacity of EPCs from CAD patients. The gene discussed is VEGFA; the disease is coronary artery disorder.